(Q42089951)

16 October 2017

Sulphadimidine, pyrimethamine and dapsone in the treatment of toxoplasmosis in mice (English)

1 reference

16 October 2017

0 references

0 references

1 reference

BEVERLEY JK

1

1 reference

16 October 2017

FRY BA

series ordinal

2

1 reference

16 October 2017

language of work or name

English

0 references

publication date

1 June 1957

1 reference

British Journal of Pharmacology

16 October 2017

1 reference

16 October 2017

12

1 reference

16 October 2017

2

1 reference

16 October 2017

189-193

1 reference

Tests of 2,4-diaminopyrimidines on toxoplasmosis

16 October 2017

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1509667

Antibacterial action and metabolism of five sulphones

29 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1509667

Daraprim as an antagonist of folic and folinic acids

29 May 2018

1 reference

12 December 2020

The pharmacological properties of 2, 4-diamino-5-p-chlorophenyl-6-ethylpyrimidine, daraprim

1 reference

12 December 2020

Diasone and promin as therapeutic agents in experimental toxoplasmosis

1 reference

12 December 2020

The effects of oral administration of aureomycin, sulfathiazole, sulfamerazine and 4,4'-diamino diphenyl sulfone on toxoplasmosis in mice

1 reference

12 December 2020

10.1111/J.1476-5381.1957.TB00119.X

Identifiers

DOI

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

13446372

1 reference